Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Feb;6(Suppl 1):S83-S86.
doi: 10.21037/tcr.2017.02.35.

Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer

Affiliations
Comment

Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer

Weimin Gao. Transl Cancer Res. 2017 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
XPO1, also known as CRM1, as a novel therapeutic target for cancers. XPO1/CRM1 is overexpressed in different cancers. XPO1/CRM1 regulates various cancer-related proteins (cargoes). XPO1/CRM1 exports its cargoes through Ran in establishing the directionality of transport across the NPC. XPO1/CRM1 can be targeted by natural or synthetic inhibitors. XPO1, exportin 1; CRM1, chromosome region maintenance 1; NPC, nuclear pore complex.

Comment on

  • XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
    Kim J, McMillan E, Kim HS, Venkateswaran N, Makkar G, Rodriguez-Canales J, Villalobos P, Neggers JE, Mendiratta S, Wei S, Landesman Y, Senapedis W, Baloglu E, Chow CB, Frink RE, Gao B, Roth M, Minna JD, Daelemans D, Wistuba II, Posner BA, Scaglioni PP, White MA. Kim J, et al. Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28. Nature. 2016. PMID: 27680702 Free PMC article.

References

    1. Cook A, Bono F, Jinek M, et al. Structural biology of nucleocytoplasmic transport. Annu Rev Biochem 2007;76:647–71. - PubMed
    1. Kau TR, Way JC, Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 2004;4:106–17. - PubMed
    1. Kim J, McMillan E, Kim HS, et al. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer. Nature 2016;538:114–7. - PMC - PubMed
    1. Kudo N, Khochbin S, Nishi K, et al. Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem 1997;272:29742–51. - PubMed
    1. Lu C, Figueroa JA, Liu Z, et al. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection. Curr Cancer Drug Targets 2015;15:575–92. - PubMed